-
Apollo Hospitals
6,900.70 5,690.80(%) -
Waaree Energies
2,590.20 1,808.65(%) -
Reliance Industr
1,288.00 1,115.55(%) -
SpiceJet
55.49 79.90(%) -
Axis Bank
1,145.75 934.00(%) -
Dixon Technolog.
16,092.55 7,772.55(%) -
Suzlon Energy
56.78 37.95(%) -
Vodafone Idea
7.44 6.60(%) -
SBI Life Insuran
1,763.00 1,935.00(%) -
Tata Motors
651.45 542.55(%) -
Bharat Electron
293.70 221.00(%) -
Tata Power Co.
382.00 326.25(%) -
Reliance Power
40.91 23.26(%) -
Eternal Ltd
226.95 146.85(%) -
HDFC Bank
1,891.90 1,430.15(%) -
Jio Financial
249.15 198.60(%) -
Mazagon Dock
2,585.00 1,046.00(%) -
Adani Energy Sol
907.00 588.25(%) -
Nip. India Nifty
266.61 242.12(%) -
Adani Green
904.00 758.00(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Medicamen Biotech Ltd Pharmaceuticals - Indian - Formulations
- Indian Private
- BSE Code : 5905.0
- ISIN : INE646B01010
-
Today’s Low
440.10 -
Today’s High
480.20

-
Open
461.40 -
Perv Close
456.80 -
52W Low
375.05 -
52W High
630.00
Key Indicators
-
P/E(TTM)
55.80
-
Mar.Cap (₹Cr.)
567.26
-
Div & Yield %
0.22
-
Book Value(₹)
173.40
-
Debt-Equity Ratio
-2.33
-
AGM Date
25-Apr-2025
-
EPS
7.98
-
P/E Ratio
55.80
Financials Ratios
-
Debt-Equity Ratio
0.14
-
Mar.Cap (₹Cr.)
567.26
-
RONW (%)
4.74
-
ROCE (%)
8.14
Score Board
-
Equity (₹ in Cr.)
12.71
-
BV (₹)
173.40
-
Sales( ₹ in Cr.)
172.39
-
NP (in Cr.)
13.30
-
NP Var(%)
-11.0
-
Div%
10.0
-
CPS (₹)
16.00
-
EPS (₹)
10.50
-
Traded Value (₹ in Lakhs)
579.53
-
52 Week High
630.00
-
52 Week Low
375.05
-
Price BSE
456.0
-
Price NSE
457.00
-
Market Capital( in Cr.)
579.53
-
P/C Ratio
28.60
-
P/E Ratio
43.60
-
Price Vs.BV
10.50
-
27-Feb-2025( 04:47)
Corporate News - Medic... - Medicamen Biotech announced th...
-
21-Feb-2025( 07:50)
Corporate News - Medic... - Medicamen Biotech will hold a...
-
11-Feb-2025( 05:46)
Results - Announcements - Medic... - Net profit of Medicamen Biotec...
-
11-Feb-2025( 05:42)
Results - Announcements - Medic... - Net profit of Medicamen Biotec...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)Particulars(INCOME) | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar | 2020 Mar | 2019 Mar |
---|---|---|---|---|---|---|
INCOME : | ||||||
Sales Turnover | 172.39 | 137.88 | 115.45 | 110.15 | 117.34 | 122.60 |
Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Sales | 172.39 | 137.88 | 115.45 | 110.15 | 117.34 | 122.60 |
Other Income | 2.30 | 2.46 | 1.72 | 0.75 | 1.91 | 3.66 |
Stock Adjustments | 13.32 | 10.30 | 3.34 | -1.04 | 1.53 | -1.39 |
Total Income | 188.01 | 150.64 | 120.51 | 109.86 | 120.78 | 124.87 |
EXPENDITURE : | ||||||
Raw Materials | 104.70 | 81.80 | 55.69 | 65.84 | 74.49 | 81.95 |
Power and Fuel Cost | 7.12 | 5.67 | 5.86 | 2.68 | 2.90 | 2.11 |
Employee Cost | 22.12 | 18.57 | 14.50 | 8.79 | 9.29 | 8.09 |
Other Manufacturing Expenses | 10.24 | 8.70 | 9.60 | 7.37 | 9.10 | 5.95 |
Selling and Administration Expenses | 12.42 | 6.65 | 7.50 | 3.94 | 4.43 | 5.30 |
Miscellaneous Expenses | 1.87 | 2.18 | 1.52 | 0.46 | 0.54 | 0.35 |
Employee Benefit Expenses | 22.12 | 18.57 | 14.50 | 8.79 | 9.29 | 8.09 |
Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Expenses | 158.46 | 123.56 | 94.69 | 89.08 | 100.75 | 103.75 |
Operating Profit | 29.55 | 27.08 | 25.82 | 20.78 | 20.03 | 21.12 |
Interest | 5.65 | 3.39 | 1.94 | 1.51 | 0.93 | 1.38 |
Gross Profit | 23.90 | 23.69 | 23.88 | 19.27 | 19.10 | 19.74 |
Depreciation | 7.01 | 6.35 | 5.77 | 2.52 | 2.50 | 2.21 |
Profit Before Tax | 16.89 | 17.34 | 18.11 | 16.75 | 16.60 | 17.53 |
Current Tax | 4.22 | 3.70 | 3.98 | 4.15 | 4.60 | 5.50 |
Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Deferred Tax | -0.63 | -1.37 | -0.78 | 0.12 | -0.25 | 0.00 |
Reported Net Profit | 13.30 | 15.00 | 14.91 | 12.49 | 12.26 | 12.03 |
Extraordinary Items | 0.00 | -0.01 | 0.00 | 0.00 | -0.04 | 0.01 |
Adjusted Net Profit | 13.30 | 15.01 | 14.91 | 12.49 | 12.30 | 12.02 |
Adjustment below Net Profit | 0.00 | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
P & L Balance brought forward | 82.15 | 68.32 | 54.43 | 42.56 | 31.77 | 19.74 |
Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Appropriations | 1.27 | 1.27 | 1.22 | 0.61 | 1.47 | 0.00 |
P & L Balance carried down | 94.18 | 82.15 | 68.12 | 54.43 | 42.56 | 31.77 |
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Equity Dividend (%) | 10.00 | 10.00 | 10.00 | 10.00 | 5.00 | 10.00 |
Dividend Per Share(Rs) | 1.00 | 1.00 | 1.00 | 1.00 | 0.50 | 1.00 |
Earnings Per Share-Unit Curr | 10.46 | 11.86 | 12.20 | 10.22 | 10.03 | 10.28 |
Earnings Per Share(Adj)-Unit Curr | 10.46 | 11.86 | 12.20 | 10.22 | 10.03 | 10.28 |
Book Value | 164.54 | 152.30 | 121.18 | 109.98 | 100.25 | 74.05 |
Book Value(Adj)-Unit Curr | 164.54 | 152.30 | 121.18 | 109.98 | 100.25 | 74.05 |